MPZL3 and ovarian neoplasm: Similar to TCGA data, primary ovarian tumors were comprised of both high- and low-expressing populations, whereas the majority of omental tumors, which represents a major site of metastasis, displayed decreased MPZL3 expression (Fig. 1D), suggesting that a loss of MPZL3 is associated with tumor progression.